Navigation Links
Cutting the risk of diabetes with a pill

With the ever-rising obesity rates all over the world sparking many lifestyle ailments like type 2 diabetes, this piece of news might just be what the doctor ordered. A pill// is soon gaining ground for preventing type 2 diabetes for those under risk. A mere consumption of the pill once or twice daily, enhances the body’s receptive mechanism to insulin in aiding better glucose management, thus offsetting diabetes.

The pill, named as rosiglitazone, marketed under the brand name Avandia by the British company GlaxoSmithKline, has just emerged out of a successful three-year trial, and is claimed to be able to assist the high-risk category of people from developing diabetes.

Nicknamed as an 'insulin sensitiser', this pill enhances the body's response to insulin, thus ensuring the removal of glucose from the blood. The clinical trial encompassed 5,269 adults from 21 countries. The group was divided on a random basis and half of the group was administered the 8mg of the pill and the rest a placebo everyday. All patients received advice about diet and lifestyle. After three years, the finding revealed that 280 of the subjects taking the drug and 658 on the placebo developed diabetes. Only sixteen patients on the drug, showed a small risk of non-fatal heart failure.

The researchers, led by Hertzel Gerstein from the Population Research Institute in Hamilton, Ontario, said 'Balancing both benefits and risks suggests that for every 1,000 people treated with rosiglitazone for three years, about 144 cases of diabetes will be prevented, with an excess of four to five cases of congestive heart failure.'
SAV
'"/>




Page: 1

Related medicine news :

1. Cutting down on alcohol may reduce cigarette craving
2. Aerobics- right choice for Cutting Blood Pressure
3. Cutting-Edge: Five Hospitals in UK Go On a Resizing Rampage
4. Pranab Mukherjee Urged Military Doctors To Remain On The Cutting Edge
5. NHS Recommends Further Cost Cutting Measures
6. Stay Young By Cutting Down Calories
7. Saving Hearts with Cutting-Edge Technology
8. Cutting Back on Salt Is a Necessity for Some, Not All
9. For Smokers Only: is Quitting = Cutting Down?? a grave Issue
10. Cardiac Risk is Reduced by Cutting the Sugar in Your Drink
11. Rapid Flu Test, Beneficial in Cutting Down Antibiotic Use
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the ... ended December 31, 2015 on Monday, February 29, 2016 after the market closes. , ... the release at 4:30 PM ET. Investors interested in participating by phone are invited ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... For ... in new book , Pioneering book "Better with Age: The Ultimate Guide to Brain ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX ... accessories. These PEEK-lined stainless steel (PLS) columns combine the strength of traditional stainless ... the integrity of biological samples while operating at ultra-high pressures of 20,000 psi. ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... The recreational ... cannabis enthusiasts in the state still face a lot of restrictions as to where ... is intended for private, personal use” and that cannabis “may not be consumed openly ...
(Date:2/10/2016)... ... 2016 , ... Ross A. Clevens, MD, FACS , ... a new addition to their growing practice. Beginning this month, Teresa Imperiale-Westerfield, a ... performing cosmetic procedures including injectables, fillers and laser treatments. A master ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Mass. , Feb. 9, 2016  Insulet Corporation (NASDAQ: ... tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s Board ... of nine directors, eight of whom are independent. ... 40 years of audit and finance experience and a deep ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... Bermuda, Feb. 9, 2016  Axovant Sciences Ltd. ... on the treatment of dementia, today announced further ... cognitive, behavioral and functional aspects of Lewy body ... in the U.S. Two out of the three ... expected to start later this quarter. In addition, ...
Breaking Medicine Technology: